A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
DOIs
Publication statusPublished - 2017
EventASCO 2017 -
Duration: 1 Jun 2017 → …

Conference

ConferenceASCO 2017
Period01/06/2017 → …

Cite this